56 related articles for article (PubMed ID: 18337237)
1. Evolving concepts of left ventricular hypertrophy.
Tikhonoff V; Casiglia E
Eur Heart J; 2008 Apr; 29(7):846-8. PubMed ID: 18337237
[No Abstract] [Full Text] [Related]
2. Characterization of the GNAQ promoter and association of increased Gq expression with cardiac hypertrophy in humans.
Frey UH; Lieb W; Erdmann J; Savidou D; Heusch G; Leineweber K; Jakob H; Hense HW; Löwel H; Brockmeyer NH; Schunkert H; Siffert W
Eur Heart J; 2008 Apr; 29(7):888-97. PubMed ID: 18326504
[TBL] [Abstract][Full Text] [Related]
3. [Role of endothelin in the development of cardiac hypertrophy].
Hasegawa H; Komuro I
Nihon Rinsho; 2004 Sep; 62 Suppl 9():617-21. PubMed ID: 15506460
[No Abstract] [Full Text] [Related]
4. A promoter polymorphism of the insulin-like growth factor-I gene is associated with left ventricular hypertrophy.
Bleumink GS; Schut AF; Sturkenboom MC; Janssen JA; Witteman JC; van Duijn CM; Hofman A; Stricker BH
Heart; 2005 Feb; 91(2):239-40. PubMed ID: 15657251
[No Abstract] [Full Text] [Related]
5. Somatic mutation of GNAQ gene is rare in common solid cancers and leukemias.
Eom HS; Kim MS; Hur SY; Yoo NJ; Lee SH
Acta Oncol; 2009; 48(7):1082-4. PubMed ID: 19551532
[No Abstract] [Full Text] [Related]
6. Functions and regulatory mechanisms of Gq-signaling pathways.
Mizuno N; Itoh H
Neurosignals; 2009; 17(1):42-54. PubMed ID: 19212139
[TBL] [Abstract][Full Text] [Related]
7. Large-scale candidate gene approach to identifying hypertension-susceptible genes.
Miyata T
Hypertens Res; 2008 Feb; 31(2):173-4. PubMed ID: 18360034
[No Abstract] [Full Text] [Related]
8. Influence of angiotensinogen and angiotensin-converting enzyme polymorphisms on cardiac hypertrophy and improvement on maximal aerobic capacity caused by exercise training.
Alves GB; Oliveira EM; Alves CR; Rached HR; Mota GF; Pereira AC; Rondon MU; Hashimoto NY; Azevedo LF; Krieger JE; Negrão CE
Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):487-92. PubMed ID: 19404196
[TBL] [Abstract][Full Text] [Related]
9. Gene polymorphisms predisposing to cardiac hypertrophy in patients with cardiac syndrome X.
Jabrocka-Hybel A; Kolasińska-Kloch W; Malczewska-Malec M; Kieć-Wilk B; Kwaśniak M; Kloch M; Dembińska-Kieć A
Folia Med Cracov; 2007; 48(1-4):57-69. PubMed ID: 19051693
[TBL] [Abstract][Full Text] [Related]
10. Elevated plasma ACE activity: no guarantee for enhanced left ventricular hypertrophy during training.
Degens H
Acta Physiol (Oxf); 2008 Oct; 194(2):95. PubMed ID: 18811912
[No Abstract] [Full Text] [Related]
11. Apoptosis inhibitors for heart disease.
Webster KA; Bishopric NH
Circulation; 2003 Dec; 108(24):2954-6. PubMed ID: 14676135
[No Abstract] [Full Text] [Related]
12. Transforming growth factor beta1 T29C gene polymorphism and hypertension: relationship with cardiovascular and renal damage.
Argano C; Duro G; Corrao S; Di Chiara T; Nuzzo D; Colomba D; Scaglione R; Licata G
Blood Press; 2008; 17(4):220-6. PubMed ID: 18821144
[TBL] [Abstract][Full Text] [Related]
13. A needle in a haystack: Sturge-Weber syndrome gene discovery.
Comi AM; Marchuk DA; Pevsner J
Pediatr Neurol; 2013 Dec; 49(6):391-2. PubMed ID: 24075845
[No Abstract] [Full Text] [Related]
14. Candidate genes for the hereditary component of cardiac hypertrophy.
van den Hoff MJ; Postma AV; Michel MC
J Hypertens; 2006 Feb; 24(2):273-7. PubMed ID: 16508570
[No Abstract] [Full Text] [Related]
15. IGF-II/mannose-6-phosphate receptor signaling induced cell hypertrophy and atrial natriuretic peptide/BNP expression via Galphaq interaction and protein kinase C-alpha/CaMKII activation in H9c2 cardiomyoblast cells.
Chu CH; Tzang BS; Chen LM; Kuo CH; Cheng YC; Chen LY; Tsai FJ; Tsai CH; Kuo WW; Huang CY
J Endocrinol; 2008 May; 197(2):381-90. PubMed ID: 18434368
[TBL] [Abstract][Full Text] [Related]
16. Genetic causation: the end of parsimony?
Padmanabhan S
J Hypertens; 2009 Aug; 27(8):1521-3. PubMed ID: 19622924
[No Abstract] [Full Text] [Related]
17. Inhibition of left ventricular remodelling in spontaneously hypertensive rats by G alpha q-protein carboxyl terminus imitation polypeptide GCIP-27 is not entirely dependent on blood pressure.
Wang XQ; Zhang HG; Cheng YQ; Li XH
Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1215-21. PubMed ID: 18518877
[TBL] [Abstract][Full Text] [Related]
18. [Left ventricular hypertrophy in patients on hemodialysis: importance of anemia].
Stojimirović B; Petrović D; Obrenović R
Med Pregl; 2007; 60 Suppl 2():155-9. PubMed ID: 18928184
[TBL] [Abstract][Full Text] [Related]
19. The ethnic profile of patients with birthmarks reveals interaction of germline and postzygotic genetics.
Polubothu S; Kinsler VA
Br J Dermatol; 2017 May; 176(5):1385-1387. PubMed ID: 28083870
[No Abstract] [Full Text] [Related]
20. Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Chinali M; de Simone G; Wachtell K; Gerdts E; Gardin JM; Boman K; Nieminen MS; Papademetriou V; Dahlöf B; Devereux RB
J Hypertens; 2008 Jul; 26(7):1472-6. PubMed ID: 18551025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
